Sofie Declercq

Sofie Declercq

Auto-generated profile, based on publicly available information

Sofie Declercq

Vrije Universiteit Brussel─Molecular Imaging and Therapy Research Group (MITH)

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2025 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Noemi DeclerckNoemi Declerck
Noemi Declerck
SDSofie Declercq
Sofie Declercq
PDPieterjan Debie
Pieterjan Debie
JVJulie Du Ville
Julie Du Ville
ŁMŁukasz Mateusiak
Łukasz Mateusiak
Sophie HernotSophie Hernot
Sophie Hernot

16 November 2026 in Bioconjugate Chemistry
Verified
Journal Article
Open access
JBJan Brokemper
Jan Brokemper
SDSofie Declercq
Sofie Declercq
NDNick Devoogdt
Nick Devoogdt
JBJessica Bridoux
Jessica Bridoux
MSMirkka P. Sarparanta
Mirkka P. Sarparanta
The recent expansion of recombinant biomolecules as diagnostic and therapeutic agents has created a strong need for mild, site-specific, and universally applicable methods to radiolabel them for positron emission tomography (PET). Fluorine-18 is one of the most widely used radionuclides for PET because it combines a clinically practical half-life, high positron intensity with low mean energy, and a non-metallic footprint in the label. However, the conditions necessary for efficient nucleophilic fluorine-18 radiolabelingbasic, anhydrous media, elevated temperature, and aprotic solventsare poorly compatible with sensitive biomolecules. Therefore, prosthetic group labeling with subsequent conjugation, both site-specific and non-site-specific, and aluminum-[18F]fluoride (Al[18F]F2+) chelation have become essential workarounds. Depending on the radiolabeling site, this can yield heterogeneous products, with impaired tracer target binding and pharmacokinetics. Enzymatic ligation offers a complementary strategy, with radiofluorination done on a robust small-molecule or peptide substrate, and subsequently, an enzyme catalyzes a mild and site-specific conjugation to a genetically encoded recognition motif on the target. This ensures that each step proceeds under its own optimal conditions. This review evaluates the current state of enzymatic and chemoenzymatic radiofluorination of biomolecules, from the early fluorinase work to recent advances with lipoic acid ligase (LplA), peptide asparaginyl ligase, and sortase A (SrtA). It further reviews enzymes and techniques that could extend this toolbox. The field is still emerging, but available evidence suggests that enzyme-mediated radiofluorination can occupy a niche between classical prosthetic-group radiochemistry and kit-like radiometal labeling, especially for fragile recombinant biomolecules whose radiolabeling with fluorine-18 is currently a challenge.